Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.25 USD | +1.49% | +1.26% | -0.09% |
Mar. 21 | Wedbush on Fennec's Q4 | MT |
Mar. 21 | Transcript : Fennec Pharmaceuticals Inc., 2023 Earnings Call, Mar 21, 2024 |
Business Summary
Number of employees: 36
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Chief Tech/Sci/R&D Officer | - | - | |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 15-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Marco Brughera
BRD | Director/Board Member | 70 | 16-08-09 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Jodi Cook
BRD | Director/Board Member | 56 | 19-09-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,040,306 | 22,264,960 ( 82.34 %) | 0 | 82.34 % |
Company contact information
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.20% | 300M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.69% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |
- Stock
- Equities
- Stock Fennec Pharmaceuticals Inc. - Nasdaq
- Company Fennec Pharmaceuticals Inc.